EAPP Antibodies

Santa Cruz Biotechnology features a diverse variety of EAPP Antibodies for research focused on understanding EAPP protein functions. EAPP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EAPP, or E2F-associated protein, plays a critical role in the regulation of gene expression and cell cycle progression. Through interaction with E2F transcription factors, EAPP influences cell proliferation and differentiation pathways. Research has shown that EAPP expression patterns vary across different tissue types and developmental stages. Understanding EAPP function continues to reveal new insights into cellular processes and disease mechanisms, particularly in cancer research. Molecular studies of EAPP have demonstrated its significance in cell cycle checkpoints and transcriptional regulation. Current investigations are expanding knowledge about EAPP's role in normal development and pathological conditions. EAPP research using Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific understanding of cell cycle regulation and disease mechanisms.